September 15, 2020 (CAMBRIDGE, MA., & SAN DIEGO, CA) – Sanofi, MassBio, and Biocom today announced a collaboration to hold the first-ever bicoastal partnering day. Sanofi Partnering Day with MassBio and Biocom unifies the two organizations to provide Sanofi with a premier portal to connect with the most innovative biotech companies, entrepreneurs, academics, research institutions, accelerators, and incubators in Massachusetts, California, and across the U.S.
This pioneering event builds on both the success of previous MassBio Pharma Days® / Biocom Partnering Days that match biopharma companies with academic and early-stage targets for partnering opportunities, and Sanofi’s virtual R&D Day series to highlight the company’s capabilities, platforms, and expertise to deliver transformative treatments to patients.
“The ability to connect and partner is the lifeblood of the industry, but those activities have been severely disrupted by the COVID-19 pandemic. Massachusetts and California are home to the largest life sciences clusters in the world and by combining our efforts and networks, MassBio and Biocom can provide a premier forum to connect biopharma stakeholders in the virtual world,” said Robert K. Coughlin, President & CEO, MassBio. “We’re honored to work with Sanofi to pioneer this novel approach and look forward to replicating this model to catalyze industry collaboration across the country.”
Sanofi Partnering Day with MassBio and Biocom will be held on Friday, October 16th, 2020 from 11:00-12:30 PM EST. During the event, Sanofi will provide an overview of its R&D efforts, corporate development strategy, business areas, and novel and fully integrated approaches to partnering, and will engage in several virtual one-on-one meetings.
“Sanofi more than ever is focused on the development of first-in-class or best-in-class medicines and sees embracing partnerships that reinforce our already strong pipeline as a key pillar of our ambitions”, said Alban de La Sablière, Head of Partnering, Sanofi. “The unprecedented times we’re facing call for agility and creativity, and we are looking forward to strengthening our relationships with innovators to drive new collaborations that can help bring transformative treatments to patients.”
Sanofi’s interest areas for the event include oncology, immunology & inflammation, rare blood disorders, rare & neurologic diseases, and vaccines.
“This represents the first time we’ve formally collaborated with MassBio on activities that help our members advance their business in important ways,” said Jennifer Landress, Senior Vice President and Chief Operating Officer, Biocom. “We truly appreciate novel ways to bring opportunities such as this to California biotechnology companies, and thanks to Sanofi for their interest in this event.”
Biotech companies and academics in Massachusetts seeking an invite to this event should contact Steve Powell at firstname.lastname@example.org and biotech companies and academics in California should contact Oscar Rodarte at email@example.com.
# # #
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.
With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.
Sanofi, Empowering Life
Biocom is the leader and advocate for California’s life science sector. We work on behalf of more than 1,300 members to drive public policy, build an enviable network of industry leaders, create access to capital, introduce cutting-edge STEM education programs, and create robust value-driven purchasing programs.
Founded in 1995 in San Diego, Biocom provides the strongest public voice to research institutions and companies that fuel the local and state-wide economy. Our goal is simple: to help our members produce novel solutions that improve the human condition. In addition to our San Diego headquarters, Biocom operates core offices in Los Angeles and the San Francisco Bay Area, satellite offices in Washington, D.C. and Tokyo, and has a continuous staff presence in Sacramento. Our broad membership benefits apply to biotechnology, pharmaceutical, medical device, genomics and diagnostics companies of all sizes, as well as to research universities and institutes, clinical research organizations, investors and service providers.
For more information on Biocom, please visit our website at www.biocom.org. Connect with us on LinkedIn, Facebook, and Twitter (@BIOCOMCA).
MassBio’s mission is to advance Massachusetts’ leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. MassBio represents the premier global life sciences and healthcare hub, with 1,300+ members dedicated to preventing, treating, and curing diseases through transformative science and technology that brings value and hope to patients. Founded in 1985, MassBio works to advance policy and promote education, while providing member programs, events, industry information, and services. For more information, visit www.massbio.org.
MassBio Media Contact:
Jennifer Nason, Senior Director of Communications
Biocom Media Contact:
Carolyn Hawley, Canale Communications